Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSPIRA TECHNOLOGIES OXY B.H.N. LTD.

(IINN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Unable to Return to Positive Ground By Wednesday Close

11/24/2021 | 04:06pm EST


ę MT Newswires 2021
All news about INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
01/28Inspira Technologies Lists ART, ECLS Systems Component on FDA's Class I Exempt List
MT
01/28INSPIRA TECHNOLOGIES OXY B H N : Component of the ART system - Form 6-K
PU
01/19INSPIRA TECHNOLOGIES OXY B H N : Technologies' Advisory Board - Form 6-K
PU
01/19Inspira Technologies OXY B.H.N. Ltd. Appoints Professor Daniel Brodie to the Scientific..
CI
01/09Certain Ordinary Shares of Inspira Technologies Oxy B.H.N. Ltd. are subject to a Lock-U..
CI
01/09Certain Warrants of Inspira Technologies Oxy B.H.N. Ltd. are subject to a Lock-Up Agree..
CI
2021INSPIRA TECHNOLOGIES OXY B H N : ARTICLES OF ASSOCIATION OF INSPIRA TECHNOLOGIES OXY B.H.N..
PU
2021Inspira Technologies Oxy B.H.N. Ltd. Terminates the Employment Agreement with Udi Nussi..
CI
2021Health Care Rise Thursday as Investors Seek Havens
MT
2021Health Care Stocks Scratching Out Modest Thursday Gains
MT
More news
Analyst Recommendations on INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -11,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,51x
Yield 2021 -
Capitalization 17,9 M 17,9 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees -
Free-Float 66,2%
Chart INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
Duration : Period :
Inspira Technologies Oxy B.H.N. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 2,30 $
Average target price 10,00 $
Spread / Average Target 335%
EPS Revisions
Managers and Directors
Dagi Shahar Ben-Noon Chief Executive Officer & Director
Joe Hayon President & Chief Financial Officer
Benad Goldwasser Chairman
Udi Nussinovitch Chief Scientific Officer & Director
Avi Shabtai COO, Vice President-Research & Development
Sector and Competitors